Amplia Therapeutics Ltd.ASX: ATX

Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial

· Issued by Amplia Therapeutics Ltd. via ASX

Filed with ASX · · 3 pages · English

Release

ABN 16 165 160 841 +61 (0) 3 9123 1140 | [email protected] Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 15 Sep 2026 ASX RELEASE AMPLIA AND ANZGOG FINALISE PROTOCOL FOR OVARIAN CANCER CLINICAL TRIAL HIGHLIGHTS • The PRROSE trial will investigate the combination...

Amplia Therapeutics Ltd. on 6ix

In the deck

Earlier from Amplia Therapeutics

Later from Amplia Therapeutics

All Amplia Therapeutics news releases